FDA Approved: DYANAVEL XR — Original Application (NextWave Pharmaceuticals, Inc)

View source ↗

Summary

FDA approves DYANAVEL XR under original NDA for the treatment of attention-deficit/hyperactivity disorder. The product is developed by NextWave Pharmaceuticals,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Dyanavel XR (amphetamine (extended-release))

Snippet

ORIG AP for DYANAVEL XR (AMPHETAMINE)